Accrued Expenses

9 Months Ended

12 Months Ended

Sep. 30, 2023

Dec. 31, 2022

Accrued Expenses

Accrued Expenses

Note 4. Accrued Expenses

The following is a summary of the Company’s accrued expenses:

	September 30,		December 31,
	2023		2022
Clinical trial expenses	$	2,082,200	$	1,884,117
Other		304,636		423,629
Total	$	2,386,836	$	2,307,746

Note 4.Accrued Expenses

The following is a summary of the Company’s accrued expenses:

	December 31,
	2022		2021
Clinical trial expenses	$	1,884,117	$	2,625,779
Other		423,629		330,766
Total	$	2,307,746	$	2,956,545